Growth Analyser Growth Analyser

Compare funds

Pick up to 10 funds. Compare funds from the same category for a fair reading.

quant Business Cycle Fund · Direct ✕HDFC Pharma and Healthcare Fund · Direct ✕

Growth of ₹10,000

Basics

quant Business Cycle FundHDFC Pharma and Healthcare Fund
CategorySectoral / ThematicSectoral / Thematic
PlanDirectDirect
Fund housequantHDFC
NAV₹17.0967₹23.6750
NAV date20 Nov 202620 Nov 2026
History3.5 years3.1 years
Expense ratio1.4%1.1%
Stars★★★★★★★★★★
Growth Score12.7094.50

Returns

quant Business Cycle FundHDFC Pharma and Healthcare Fund
1 month+3.81%+12.97%
3 months−0.36%+7.13%
6 months+1.84%+17.84%
YTD+5.09%+33.73%
1 year+2.37%+32.20%
3 years (CAGR)+9.64%+30.70%
5 years (CAGR)——
10 years (CAGR)——
Since launch+16.64%+31.83%

Risk

quant Business Cycle FundHDFC Pharma and Healthcare Fund
Volatility20.0%15.8%
Downside volatility13.6%8.5%
Sharpe0.161.53
Sortino0.232.86
Calmar0.332.06
Return / risk0.481.95
Deepest fall−29.25%−14.91%
Days to recover—126
Below its high−13.78%+0.00%

Against benchmark

quant Business Cycle FundHDFC Pharma and Healthcare Fund
Alpha−2.36%+7.54%
Beta1.100.97
R²78.2%85.0%
Up capture105.1%108.9%
Down capture123.8%71.0%
Tracking error9.5%6.1%
Information ratio−0.191.17
Treynor0.020.24

Consistency

quant Business Cycle FundHDFC Pharma and Healthcare Fund
Best 1-year+74.43%+67.01%
Middle 1-year+3.35%+23.25%
Worst 1-year−19.69%+1.71%
1-year periods with a loss38.1%0.0%
Middle 3-year+14.70%+30.22%
Positive months61.1%72.2%
Best day+4.53%+3.18%
Worst day−7.79%−3.61%
Worst 5% day−1.81%−1.51%
Positive days55.3%58.3%
NAVs a year247247

SIP of ₹10,000 a month

quant Business Cycle FundHDFC Pharma and Healthcare Fund
5-year XIRR——
5-year value——
3-year XIRR+3.46%+27.71%
1-year XIRR+7.50%+41.37%

Holdings overlap i

Overlap needs the monthly portfolio filing of at least two of these funds; not loaded yet.

Search Growth